[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Morineaux et al., 2013 - Google Patents

Characterization of different subtypes of botulinum type A toxins by mass spectrometry

Morineaux et al., 2013

Document ID
13685348421082297023
Author
Morineaux V
Hilaire D
Mazuet C
Enche J
Popoff M
Publication year
Publication venue
Abstracts/Toxicon

External Links

Snippet

Botulinum toxins are more and more used as therapeutic treatment but they are also considered as one of the major potential threat agent due to their highly toxicity. These toxins can be produced by 7 types of Clostridium botulinum: A to G and among them …
Continue reading at www.academia.edu (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Similar Documents

Publication Publication Date Title
Lazcano-Pérez et al. Bioactive peptides from marine organisms: a short overview
CL2019003000A1 (en) Trem2 antigen binding proteins and their uses.
CO2017007665A2 (en) Icos binding proteins
MX2020010806A (en) Anti-inflammatory peptides, and uses thereof.
MX2021006017A (en) Methods and compositions for treatment of disorders with follistatin polypeptides.
PE20240015A1 (en) GDF15 FUSION PROTEINS AND USES OF THESE
US9062125B2 (en) Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmission
PE20140673A1 (en) NEW MODULATORS AND METHODS FOR THEIR USE
EA201992755A1 (en) NEW MONOCLONAL ANTIBODIES FOR PROTEIN 4 ASSOCIATED WITH CYTOTOXIC T-Lymphocytes, (CTLA-4)
BR112018000903A2 (en) compositions and methods for cancer treatment
EA201892548A1 (en) ANTIBODIES TO ALPHA-SINUCULINE AND THEIR APPLICATION
EA201200515A1 (en) POLYPEPTIDES AND THEIR APPLICATION
Erdeş et al. Characterization of Leiurus abdullahbayrami (Scorpiones: Buthidae) venom: peptide profile, cytotoxicity and antimicrobial activity
PE20190743A1 (en) METHODS FOR THE TREATMENT OF MUSCULAR ATROPHY AND OSEA DISEASE WITH THE USE OF NOVEDOUS HYBRID TRAP PROTEINS OF THE ACTRIIB BINDING
EA200970694A1 (en) PEHYLATED Fab ANTIBODY FRAGMENTS TO Aβ PEPTIDE
RU2015113348A (en) CELLING PEPTIDES IN CELLS BINDING INTERFERON-REGULATING FACTOR 5
WO2009009727A3 (en) Ghrh analogs and therapeutic uses thereof
PE20171336A1 (en) ANTIBODIES AGAINST TAU AND ITS USES
RU2017103679A (en) METHOD FOR INHIBITING AN INTRA-CELLULAR ACTIVATED RAS USING AN INTACT ANTIBODY OF AN IMMUNOGLOBULIN TYPE WITH THE ABILITY TO PERFORMANCE IN CYTOSOL, AND ITS APPLICATION
EA201790341A1 (en) ANTI-CK8 ANTIBODIES FOR USE IN TREATMENT OF CANCER
BR112013019513A2 (en) Methods for treating diabetic foot ulcers
AR068020A1 (en) COMBINED THERAPY FOR PANCREAS CANCER USING AN ANTIGEN PEPTIDE AND A CHEMOTHERAPEUTIC AGENT
EP4349360A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
CY1114619T1 (en) SYNTHETIC ANALOGES OF NEURAL ANALYSIS Peptides
Ferreira et al. Evaluation of antimicrobial, cytotoxic, and hemolytic activities from venom of the spider Lasiodora sp.